María B Vidriales

Summary

Affiliation: Universidad de Salamanca
Country: Spain

Publications

  1. ncbi request reprint Immunologic monitoring in adults with acute lymphoblastic leukemia
    Maria Belen Vidriales
    Hematology Department, University Hospital of Salamanca, Paseo de San Vicente 58 182, 37007 Salamanca, Spain
    Curr Oncol Rep 5:413-8. 2003
  2. ncbi request reprint Minimal residual disease monitoring by flow cytometry
    María B Vidriales
    Department of Haematology, University Hospital, Paseo de San Vicente 58 182, 37007, Salamanca, Spain
    Best Pract Res Clin Haematol 16:599-612. 2003
  3. ncbi request reprint Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML)
    Jesus F San-Miguel
    Department of Haematology, University Hospital of Salamanca, Paseo de San Vicente 58 182, 37007 Salamanca, Spain
    Best Pract Res Clin Haematol 15:105-18. 2002
  4. doi request reprint High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
    Carlos M Santamaría
    Hospital Universitario, Salamanca, Spain Centro de Investigación Del Cáncer IBMCC USAL CSIC of Salamanca, Spain
    Leuk Res 33:1706-9. 2009

Collaborators

  • Alberto Orfao
  • Jesus F San-Miguel
  • Ramon Garcia-Sanz
  • Carlos M Santamaría
  • Miguel Alcoceba
  • Juan N Rodriguez
  • Abelardo Barez
  • Cristina Perez
  • Jose A Queizan
  • Marcos Gonzalez
  • Maria E Sarasquete
  • Jose M Alonso
  • Pilar Giraldo
  • María J Peñarrubia
  • Maria D Caballero
  • Teresa Bernal
  • Joaquin Diaz-Mediavilla
  • Jesus F San Miguel
  • Pascual Fernandez-Abellan
  • Alfonso García de Coca
  • Fernando Ramos
  • Ana Balanzategui
  • María C Chillón

Detail Information

Publications4

  1. ncbi request reprint Immunologic monitoring in adults with acute lymphoblastic leukemia
    Maria Belen Vidriales
    Hematology Department, University Hospital of Salamanca, Paseo de San Vicente 58 182, 37007 Salamanca, Spain
    Curr Oncol Rep 5:413-8. 2003
    ....
  2. ncbi request reprint Minimal residual disease monitoring by flow cytometry
    María B Vidriales
    Department of Haematology, University Hospital, Paseo de San Vicente 58 182, 37007, Salamanca, Spain
    Best Pract Res Clin Haematol 16:599-612. 2003
    ..Current knowledge indicates that MRD studies using well-tested methodologies are clinically useful and should be incorporated into the clinical management of patients with acute leukaemia...
  3. ncbi request reprint Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML)
    Jesus F San-Miguel
    Department of Haematology, University Hospital of Salamanca, Paseo de San Vicente 58 182, 37007 Salamanca, Spain
    Best Pract Res Clin Haematol 15:105-18. 2002
    ..Although reported data in the literature are still scanty, several authors have shown that this technique could be used for the prognostic evaluation of AML patients, when immunophenotypic evaluation is applied after induction therapy...
  4. doi request reprint High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
    Carlos M Santamaría
    Hospital Universitario, Salamanca, Spain Centro de Investigación Del Cáncer IBMCC USAL CSIC of Salamanca, Spain
    Leuk Res 33:1706-9. 2009
    ..We concluded that FOXO3a assessment could contribute to improve the molecular-based risk stratification in CN-AML...